Discussion with Dr. William Makis | Covid Intel

Dr. William Makis, oncologist and founder of research group Covid Intel talks health and wellness. Dr. Makis covers his background as an oncologist, his research and findings over the years during and after the 2020 experiment, his view of the big pharma model, vaccine injury, his work with patients globally, alternative cancer treatment methods, big food, tips on wellness, fasting, and more. #Wellness #Health #Investing #Cancer #Diet #Fasting #Ivermectin #MakisMD #Covidvaccine #Bigpharma #Food

Learn more about Dr. Makis and Covid Intel: https://makismd.substack.com/
Join us on Twitter(X): https://x.com/SmithWeekly
Watch this program on Rumble, an alternative to YouTube: https://rumble.com/c/c-6540709
Get the latest alerts on our research, portfolio, & more: https://smithweekly.com

IMPORTANT NOTICE
Join the SmithWeekly community:
https://smithweekly.com
https://x.com/SmithWeekly

Copyright © SmithWeekly Research. All rights reserved.
SmithWeekly Discussions was setup to give the audience of SmithWeekly Research additional insights, non-promotional candid discussion, and questioning that is unconventionally fresh. This is an unscripted audio discussion that takes place in our virtual conference room. Questions are solicited from SmithWeekly Research Audience as well as questions generated internally. We do not provide guests any questions upfront nor do we allow any scripted attempts by our guests. Audio is edited for technical purposes only. If the discussion is requested by the guest to be edited for content reasons, we will review the content and render a decision to edit. If the discussion is edited for content reasons that we deem material, the audience will be informed. SmithWeekly does not pay the guests who come on this program. Other than production costs, SmithWeekly does not accept any compensation from the guests or the companies they represent. SmithWeekly Discussions is a free program to our audiences and is at the expense of SmithWeekly. This program is a private discussion and everything contained herein is for entertainment and educational purposes only. The opinions expressed in this discussion are those of the host and guests. They do not purport to reflect the opinions or views of SmithWeekly Research. Nothing in this discussion constitutes a recommendation of any company mentioned nor does the appearance of a guest representing a company mean SmithWeekly has a positive view of the company or companies mentioned. Our audiences are cautioned that SmithWeekly Discussions should not be considered as a source of due diligence or a replacement for your own due diligence, which is your responsibility. If our guest represents a listed company, you must review their disclosures and technical data available on their website and filed with applicable regulatory agencies. Therefore, you are cautioned that the guest could make forward looking statements in this discussion. SmithWeekly is not responsible for any comments made by the guests including any comments that may be subject to regulatory restrictions. SmithWeekly Research, with or without notice, may determine to change our policies at anytime. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from the SmithWeekly Group. Written versions (transcripts) may be inaccurate and may not fully discern the audio version in the way the speakers intended. Translation errors and data errors may exist in the written version. By listening to, using in any way, downloading, reading or using our website, you automatically agree to our Terms of Use stated on our website.

Record Date: 18DEC2024